Affinivax, Astellas begin clinical quest to beat Pfizer's Goliath with a new kind of pneumococcal vaccine
Days after the FDA blessed Merck’s effort to challenge Pfizer’s mega-blockbuster Prevnar 13 with a breakthrough designation, Affinivax is making the leap into the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.